LifeMD shares fell 4.89% to $2.17, trailing a 35% month‑to‑date drop. With a 200‑day average at $3.73, investors see volatility amid mixed peer results.
LFMD stock falls to a 52‑week low, trading flat at $2.14 amid thin liquidity and a 30% decline, leaving investors wary of its telehealth model and valuation.